18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China
- Status
- COMPLETED
- Phase
- PHASE1
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer
- Status
- TERMINATED
- Phase
- NA
A Study of LY3435151 in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Body Composition and Prognosis in Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- WITHDRAWN
- Phase
- N/A
Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
- Status
- TERMINATED
- Phase
- PHASE1